BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 29217175)

  • 1. Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients.
    Miao G; He Y; Lai K; Zhao Y; He P; Tan G; Wang X
    J Control Release; 2023 Nov; 363():12-26. PubMed ID: 37717659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum.
    Neun BW; Dobrovolskaia MA
    Methods Mol Biol; 2024; 2789():185-192. PubMed ID: 38507004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated liposomes for diagnosis of polyethylene glycol allergy.
    Perkins GB; Tunbridge MJ; Hurtado PR; Zuiani J; Mhatre S; Yip KH; Le TA; Yuson C; Kette F; Hissaria P
    J Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38718949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both IgM and IgG Antibodies Against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice.
    Chang TC; Chen BM; Lin WW; Yu PH; Chiu YW; Chen YT; Wu JY; Cheng TL; Hwang DY; Roffler AS
    Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents.
    Sakai H; Kure T; Kobayashi N; Ito T; Yamada Y; Yamada T; Miyamoto R; Imaizumi T; Ando J; Soga T; Osanai Y; Ogawa M; Shimizu T; Ishida T; Azuma H
    ACS Omega; 2024 Jan; 9(1):1904-1915. PubMed ID: 38222647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in silico method to assess antibody fragment polyreactivity.
    Harvey EP; Shin JE; Skiba MA; Nemeth GR; Hurley JD; Wellner A; Shaw AY; Miranda VG; Min JK; Liu CC; Marks DS; Kruse AC
    Nat Commun; 2022 Dec; 13(1):7554. PubMed ID: 36477674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy.
    Han X; Zhang G; Wu X; Xu S; Liu J; Wang K; Liu T; Wu P
    J Nanobiotechnology; 2024 Mar; 22(1):90. PubMed ID: 38439048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors.
    Dobrovolskaia MA; Bathe M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1657. PubMed ID: 32672007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.
    Mohammadpour R; Dobrovolskaia MA; Cheney DL; Greish KF; Ghandehari H
    Adv Drug Deliv Rev; 2019 Apr; 144():112-132. PubMed ID: 31295521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review.
    Shiraishi K; Yokoyama M
    Sci Technol Adv Mater; 2019; 20(1):324-336. PubMed ID: 31068982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Viral Delivery To Enable Genome Editing.
    Rui Y; Wilson DR; Green JJ
    Trends Biotechnol; 2019 Mar; 37(3):281-293. PubMed ID: 30278987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
    Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
    J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell-intrinsic toll-like receptor 7 is responsible for the enhanced anti-PEG IgM production following injection of siRNA-containing PEGylated lipoplex in mice.
    Hashimoto Y; Abu Lila AS; Shimizu T; Ishida T; Kiwada H
    J Control Release; 2014 Jun; 184():1-8. PubMed ID: 24727075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
    Ishida T; Kiwada H
    Yakugaku Zasshi; 2008 Feb; 128(2):233-43. PubMed ID: 18239370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS; Kiwada H; Ishida T
    J Control Release; 2013 Nov; 172(1):38-47. PubMed ID: 23933235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens.
    Ando H; Abu Lila AS; Kawanishi M; Shimizu T; Okuhira K; Ishima Y; Ishida T
    J Control Release; 2018 Jan; 270():114-119. PubMed ID: 29217175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes.
    Shimizu T; Lila ASA; Kitayama Y; Abe R; Takata H; Ando H; Ishima Y; Ishida T
    Biol Pharm Bull; 2024; 47(2):469-477. PubMed ID: 38383000
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.